In The News

Ropes & Gray Honored With Five 2022 LMG Life Sciences Americas Awards

Practices: Mergers & Acquisitions, Capital Markets, Health Care, Technology, Media & Telecommunications, Securities & Public Companies, Litigation, Private Equity, Capital Solutions & Private Credit, Government Enforcement, False Claims Act, Anti-Corruption / International Risk Industries: Healthcare & Life Sciences

At a ceremony on September 8, Ropes & Gray was honored with five LMG Life Sciences Americas Awards for 2022.

Ropes & Gray was awarded “Government Investigations Firm of the Year,” “M&A Firm of the Year” and “Life Cycle Firm of the Year – United States.”

In addition, mergers & acquisitions partner Emily Oldshue was named “U.S. Rising StarFinancial & Corporate.”

The firm was also honored in the category of “Impact Deals of the Year” for advising Pfizer in its $11.6 billion acquisition of Biohaven Pharmaceuticals. Led by Emily Oldshue, the Biohaven transaction features the acquisition by Pfizer of Biohaven’s migraine and calcitonin gene-related peptide (CGRP) programs, including Nurtec ODT and zavegepant, following a pre-closing spin-off of Biohaven’s non-CGRP programs into a new public company.

The LMG Life Sciences Awards honor top-ranking firms and individuals for outstanding life sciences legal work in practice areas including regulatory, intellectual property, financial and corporate, and litigation and enforcement.

Cookie Settings